Armata Pharmaceuticals, Inc. cotiza a 3.63 USD y tiene una capitalización bursátil de $135M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP…
| Periodo | 2026-11 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-3.16 | $-0.36 | $-0.33 |
| Estimado | $-0.56 | $-0.38 | $-0.19 | $-0.42 |
| Sorpresa | — | -731.6% | -89.5% | +21.4% |
| Métrica | ARMP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -747.0% | -38.6% | -708.4% |
| Net Margin | -3544.0% | -33.6% | -3510.5% |
| FCF Margin | -536.4% | -13.9% | -522.5% |
| ROE | — | -40.4% | — |
| ROA | -226.1% | -32.0% | -194.1% |
| Current Ratio | 1.19 | 2.84 | -1.65 |
| Debt / Equity | — | 0.28 | — |